|
9-Bromo-11,17,21-trihydroxypregn-4-ene-3,20-dione 21-acetate
|
醋酸氟氫可的松上溴物
|
50733-54-5
|
|
Norethindrone Acetate Impurity 7
|
炔諾酮雜質(zhì)7
|
438244-27-0
|
|
21-Acetyloxy DeschloroMoMetasone Furoate
|
糠酸莫米松雜質(zhì)52
|
83897-05-6
|
|
Nitazoxanide Impurity 1
|
硝唑尼特雜質(zhì)1
|
402848-76-4
|
|
VWLTWMGSJXSKQJ-ROXMPKABSA-N
|
潑尼松龍雜質(zhì)
|
17652-24-3
|
|
112,21-dihydroxypregna-1,4,16-triene-3,20-dione
|
布地奈德雜質(zhì)Q
|
3103-17-1
|
|
16alpha-Hydroxyprednisonlone acetate
|
16α羥基潑尼松龍醋酸酯
|
86401-80-1
|
|
Pregna-1,4,9(11)-triene-3,20-dione, 21-(acetyloxy)-17-[(2-furanylcarbonyl)oxy]-16-methyl-, (16α)-
|
糠酸莫米松雜質(zhì)
|
83880-61-9
|
|
Triamcinolone Acetonide Acetate
|
醋酸曲安奈德(API)
|
3870-07-3
|
|
Fluticasone Impurity 17
|
氟替卡松雜質(zhì)17
|
1648562-63-3
|
|
Budesonide Impurity 7
|
布地奈德雜質(zhì)7
|
3949-79-9
|
|
Loteprednol Impurity
|
氯替潑諾雜質(zhì)
|
207670-57-3
|
|
Triamcinolone
|
曲安西龍(曲安奈德API)
|
124-94-7
|
|
16alpha,17,21-trihydroxypregna-1,4,9(11)-triene-3,20-dione 21-acetate
|
布地奈德雜質(zhì)12
|
77017-20-0
|
|
3-(3,4-Dimethoxyphenyl)glutaric acid
|
|
34811-27-3
|
|
Methylprednisolone 17-Propionate
|
甲潑尼龍雜質(zhì)
|
79512-61-1
|
|
(11β,16α)-21-(Acetyloxy)-11,16,17-trihydroxypregna-1,4,14-triene-3,20-dione
|
布地奈德雜質(zhì)5
|
131918-72-4
|
|
Prednisone impurity D (EP)
|
潑尼松雜質(zhì)D
|
10184-69-7
|
|
Mometasone Furoate Impurity V
|
糠酸莫米松EP雜質(zhì)V
|
109183-56-4
|
|
11BETA-HYDROXYPROGESTERONE
|
11B-羥孕酮（氫化可的松雜質(zhì)）
|
600-57-7
|
|
Diflorasone 17-propionate
|
鹵倍他索雜質(zhì)
|
924726-89-6
|
|
Fluticasone furoate impurity 10
|
糠酸氟替卡松雜質(zhì)10
|
398454-98-3
|
|
Ciclesonide
|
環(huán)索奈德
|
126544-47-6
|
|
Pregna-1,4,16-triene-3,20-dione, 21-(acetyloxy)-9-bromo-11-hydroxy-, (11β)-
|
布地奈德雜質(zhì)
|
131711-17-6
|
|
Hydrocortisone Acetate Impurity 2
|
醋酸氫化可的松雜質(zhì)2
|
4383-30-6
|
|
Nitazoxanide Impurity 4
|
硝唑尼特雜質(zhì)4
|
40045-50-9
|
|
21-Hydroxy-pregna-1,4,16-triene-3,11,20-trione 21-Acetate
|
布地奈德雜質(zhì)
|
82423-35-6
|
|
Norethindrone Acetate Impurity 13
|
炔諾酮雜質(zhì)13
|
40228-41-9
|
|
11β-hydroxy-3,20-dioxopregn-4-en-21-al
|
氫化可的松雜質(zhì)
|
20287-97-2
|
|
2-[(1S,2S,10S,11S,15S,17S)-2,15-dimethyl-5-oxo-18-oxapentacyclo[8.8.0.0^{1,17}.0^{2,7}.0^{11,15}]octadeca-3,6,13-trien-14-yl]-2-oxoethyl acetate
|
布地奈德雜質(zhì)
|
103466-44-0
|
|
Nitazoxanide Impurity 2
|
硝唑尼特雜質(zhì)2
|
952686-58-7
|
|
(6α,11β)-11,21-Dihydroxy-6-methyl-pregna-1,4-diene-3,20-dione
|
甲潑尼龍雜質(zhì)23
|
103744-18-9
|
|
|
甲潑尼龍雜質(zhì)
|
250216-21-8
|
|
Nitazoxanide Impurity 3
|
硝唑尼特雜質(zhì)3
|
121-66-4
|
|
|
氫化可的松雜質(zhì)
|
7780-63-4
|
|
Budesonide Impurity 43
|
布地奈德雜質(zhì)43
|
131918-67-7
|
|
Fluticasone propionate Impurity K
|
丙酸氟替卡松 雜質(zhì)K
|
1174034-79-7
|
|
11-Deoxy Prednisone Acetate
|
潑尼松龍雜質(zhì)11
|
1249-67-8
|
|
Budesonide Impurity 11
|
布地奈德雜質(zhì)11
|
39672-76-9
|
|
11β-hydroxy-16α,17α-isopropylidenedioxy-3-oxo-9α-fluoroandrosta-1,4-diene-17β-carboxylic acid
|
曲安奈德雜質(zhì) 19
|
3800-28-0
|
|
Androsta-1,4-diene-17-carbothioic acid, 6,9-difluoro-17-[(2-furanylcarbonyl)oxy]-16-methyl-3,11-dioxo-, S-(fluoromethyl) ester, (6α,16α,17α)-
|
糠酸氟替卡松雜質(zhì)05
|
397864-56-1
|
|
11β-Hydroxyandrost-4-ene-3,17-dione
|
11β-羥基雄甾-4-烯-3,17-二酮（氫化可的松雜質(zhì)）
|
382-44-5
|
|
(r)-budesonide
|
右布地奈德
|
51372-29-3
|
|
Desisobutyryl Ciclesonide
|
去異丁基環(huán)索奈德（環(huán)索奈德雜質(zhì)）
|
161115-59-9
|
|
16α,17,21-Trihydroxy-pregna-1,4-diene-3,11,20-trione
|
布地奈德雜質(zhì)8
|
3754-05-0
|
|
Prednisolone Acetate EP Impurity E
|
潑尼松龍醋酸EP雜質(zhì)E
|
4380-55-6
|
|
Fluticasone Impurity L
|
氟替卡松雜質(zhì)L
|
59860-80-9
|
|
11beta,17,21-trihydroxypregna-1,4-diene-3,20-dione 21-methanesulphonate
|
11Β,17Α-二羥基-21-(甲磺酰氧基)孕甾-1,4-二烯-3,20-二酮
|
35410-28-7
|
|
6a-Methylprednisone 21-Acetate
|
醋酸甲潑尼龍EP雜質(zhì)K
|
115321-98-7
|
|
Norethindrone Acetate Impurity 10
|
炔諾酮雜質(zhì)10
|
106765-04-2
|
|
Triamcinolone Acetonide Impurity 14
|
曲安奈德雜質(zhì)14
|
10392-75-3
|
|
|
氟替卡松雜質(zhì)
|
397864-58-3
|
|
Desonide 1,2-Saturated
|
地索奈德1,2飽和（地索奈德雜質(zhì)）
|
638-93-7
|
|
CORTICOSTERONE
|
腎上腺酮（皮質(zhì)酮）
|
50-22-6
|
|
Budesonide Impurity 49
|
布地奈德雜質(zhì)49
|
76282-98-9
|
|
Hydrocortisone 21-Butyrate
|
21-丁酸氫化可的松
|
6677-99-2
|
|
Corticosterone Impurity 1
|
皮質(zhì)酮雜質(zhì)1
|
2394-25-4
|
|
Pregna-1,4,9(11)-triene-3,20-dione,21-(acetyloxy)-17-hydroxy-6-methyl-, (6a)-
|
甲潑尼龍雜質(zhì)24
|
93239-37-3
|
|
2-oxo-2-[(4aS,4bS,5aS,6aS,6bS,9aR,10aS,10bS)-4a,6a,8,8-tetramethyl-2-oxo-2,5a,6,6a,9a,10,10a,10b,11,12-decahydronaphtho[2’,1’:4,5]oxireno[5,6]indeno[1,2-d][1,3]dioxol-6b(4aH)-yl]ethyl acetate
|
地索奈德雜質(zhì)
|
25092-32-4
|
|
Ciclesonide 21-Cyclohexanoyl Analog
|
環(huán)索奈德雜質(zhì)
|
1005416-98-7
|
|
Budesonide Impurity 6
|
布地奈德雜質(zhì)6
|
131918-73-5
|
|
Loteprednol Impurity 5
|
氯替潑諾雜質(zhì)
|
182069-19-8
|
|
Cortisone 21-hemisuccinate
|
氫化可的松雜質(zhì)
|
10215-75-5
|
|
6α-Methyl Hydrocortisone 21-Acetate
|
6α-甲基氫化可的松 21-乙酸酯
|
1625-11-2
|
|
Norethindrone Acetate Impurity 14
|
炔諾酮雜質(zhì)14
|
64850-62-0
|
|
Loteprednol etabonate
|
依碳氯替潑諾
|
82034-46-6
|
|
Fluticasone Impurity
|
氟替卡松雜質(zhì)
|
948565-92-2
|
|
21-acetoxy-11α,17-dihydroxy-pregna-1,4-diene-3,20-dione
|
潑尼松龍雜質(zhì)
|
3597-59-9
|
|
Budesonide Impurity 33
|
布地奈德雜質(zhì)33
|
1436872-65-9
|
|
Pregna-1,4-diene-3,20-dione, 9-chloro-11β,16α,17,21-tetrahydroxy- (6CI,7CI)
|
曲安奈德雜質(zhì)
|
95698-70-7
|
|
|
氟替卡松雜質(zhì)
|
192191-51-8
|
|
6α-Hydroxyhydrocortisone
|
氫化可的松雜質(zhì)
|
50-06-5
|
|
5-Iodomethyl 6a,9a-Difluoro-11-hydroxy-16a-methyl-3-oxo-17a-(propionyloxy)-androsta-1,4-diene-17-carbothioate
|
氟替卡松雜質(zhì)
|
80474-67-5
|
|
Triamcinolone EP Impurity C
|
曲安西龍EP雜質(zhì)C
|
337-02-0
|
|
cortienic acid
|
反式-2-丁烯酸（氫化可的松雜質(zhì)）
|
3597-45-3
|
|
Fluticasone IMpurity
|
氟替卡松雜質(zhì)
|
62800-60-6
|
|
Pregna-1,4,9(11)-triene-3,20-dione, 17-[(2-furanylcarbonyl)oxy]-21-hydroxy-16-methyl-, (16α)-
|
糠酸莫米松雜質(zhì)
|
83880-62-0
|
|
Cloticasone propionate
|
氯硫卡松丙酸酯
|
80486-69-7
|
|
Pregn-4-ene-3,20-dione, 21,21'-(1,4-dioxo-1,4-butanediyl)bis(oxy)]bis[11,17-dihydroxy-
|
氫化可的松雜質(zhì)
|
106597-71-1
|
|
(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthrene-17-carboxylic dimethylcarbamic thioanhydride
|
丙酸氟替卡松 雜質(zhì)14
|
709002-84-6
|
|
Androsta-1,4-diene-17-carboxylic acid, 11-hydroxy-17-[(methoxycarbonyl)oxy]-3-oxo-, (11β,17α)- (9CI)
|
氯替潑諾雜質(zhì)
|
265651-76-1
|
|
Pregna-1,4-diene-3,11,20-trione, 17,21-dihydroxy-6-methyl-, (6β)-
|
甲潑尼龍雜質(zhì)
|
111264-84-7
|
|
Pregna-1,4-diene-3,20-dione, 17,21-bis(acetyloxy)-11-hydroxy-6-methyl-, (6α,11β)-
|
甲潑尼龍雜質(zhì)
|
86413-24-3
|
|
Norethindrone Acetate Impurity 3
|
炔諾酮雜質(zhì)3
|
1175129-26-6
|
|
Pregna-1,4,6,9(11)-tetraene-3,20-dione 17,21-dihydroxy- (7CI)
|
潑尼松龍雜質(zhì)
|
95002-35-0
|
|
Androsta-1,4-diene-17-carbo(thioperoxoic) acid, 6,9-difluoro-11-hydroxy-16-methyl-3-oxo-17-(1-oxopropoxy)-, SO-(fluoromethyl) ester, (6α,11β,16α,17α)-
|
氟替卡松雜質(zhì)
|
948566-13-0
|
|
|
氟替卡松雜質(zhì)
|
185536-05-4
|
|
11beta,21-dihydroxypregna-4,16-diene-3,20-dione 21-acetate
|
布地奈德雜質(zhì)
|
21720-47-8
|
|
Lactic Acid Impurity 113
|
乳酸雜質(zhì)113
|
1127302-18-4
|
|
Loteprednol Impurity
|
氯替潑諾雜質(zhì)
|
78261-67-3
|
|
Norethindrone Acetate Impurity 9
|
炔諾酮雜質(zhì)9
|
50717-99-2
|
|
Fluticasone IMpurity24
|
丙酸氟替卡松 雜質(zhì)24
|
74131-81-0
|
|
Mometasone Furoate Impurity
|
糠酸莫米松雜質(zhì)
|
83880-63-1
|
|
|
磷霉素雜質(zhì)12
|
27357-50-2
|
|
Pregn-4-ene-3,20-dione, 21-chloro-9-fluoro-11,16,17-trihydroxy-, (11β,16α)-
|
哈西奈德脫丙叉雜質(zhì)（地索奈德雜質(zhì)）
|
982-91-2
|
|
Fluticasone Impurity 20
|
氟替卡松雜質(zhì)20
|
398454-97-2
|
|
2-((8S,9S,10R,11S,13S,14S)-11-acetoxy-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15-decahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate
|
布地奈德雜質(zhì)
|
23825-05-0
|
|
21-Acetoxy-16α,17-isopropylidendioxy-pregna-1,4-dien-3,11,20-trion
|
地索奈德雜質(zhì)
|
3754-07-2
|
|
Thiodicarbonic diamide ([(H2N)C(S)]2O), N,N,N',N'-tetramethyl-
|
氟替卡松雜質(zhì)
|
854886-27-4
|
|
Norethindrone Acetate Impurity 19
|
炔諾酮雜質(zhì)19
|
19793-20-5
|